Tissue-specific differences in inflammatory infiltrate and matrix metalloproteinase expression in adipose tissue and liver of mice with diet-induced obesity

Hepatology Research

Volumn 42, Issue 6, 2012, Pages 601-610

  de Meijer, Vincent E ^a,c   Sverdlov, Deanna Y ^b   Le, Hau D ^a   Popov, Yury ^b   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Fatty liver; Fibrosis; Inflammation; Macrophages; Matrix metalloproteinases; Non alcoholic fatty liver disease

Indexed keywords

COLLAGENASE 3; MACROPHAGE ELASTASE; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; FATTY LIVER; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; INTRAABDOMINAL FAT; LIPID DIET; LIVER; LIVER FIBROSIS; MACROPHAGE; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84860670654     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2011.00960.x     Document Type: Article

References (26)

1. World Health Organization. Fact sheet 311: obesity and overweight. 2011. [Cited 25 Aug 2011.] Available from URL:
2. Lazo M, Clark JM. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin Liver Dis 2008; 28: 339-50.
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
4. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009; 51: 371-9.
5. Sanyal AJ. Mechanisms of disease: pathogenesis of nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 46-53.
6. Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006; 444: 860-7.
7. Manicone AM, McGuire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol 2008; 19: 34-41.
8. Deng ZB, Liu Y, Liu C etal. Immature myeloid cells induced by a high-fat diet contribute to liver inflammation. Hepatology 2009; 50: 1412-20.
9. Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009; 50: 1294-306.
10. De Meijer VE, Sverdlov DY, Popov Y etal. Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice. PLoS ONE 2010; 5: e11256.
11. Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008; 134: 1655-69.
12. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005; 115: 209-18.
13. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008; 371: 838-51.
14. De Meijer VE, Le HD, Meisel JA etal. Dietary fat intake promotes the development of hepatic steatosis independently from excess caloric consumption in a murine model. Metabolism 2010; 59: 1092-105.
15. De Meijer VE, Le HD, Meisel JA, Puder M. Repetitive orogastric gavage affects the phenotype of diet-induced obese mice. Physiol Behav 2010; 100: 387-93.
16. De Meijer VE, Kalish BT, Puder M, IJzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. Br J Surg 2010; 97: 1331-9.
17. Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis 2010; 30: 245-57.
18. Duffield JS, Forbes SJ, Constandinou CM etal. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 2005; 115: 56-65.
19. Popov Y, Sverdlov DY, Bhaskar KR etal. Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis. Am J Physiol Gastrointest Liver Physiol 2010; 298: G323-334.
20. Harty MW, Papa EF, Huddleston HM etal. Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 2008; 143: 667-78.
21. Iredale JP, Benyon RC, Pickering J etal. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-49.
22. Maquoi E, Munaut C, Colige A, Collen D, Lijnen HR. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. Diabetes 2002; 51: 1093-101.
23. Chavey C, Mari B, Monthouel MN etal. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-96.
24. Fallowfield JA, Mizuno M, Kendall TJ etal. Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007; 178: 5288-95.
25. Stanton MC, Chen SC, Jackson JV etal. Inflammatory signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice. J Inflamm 2011; 8: 8.
26. Duval C, Thissen U, Keshtkar S etal. Adipose tissue dysfunction signals progression of hepatic steatosis towards nonalcoholic steatohepatitis in C57BL/6 mice. Diabetes 2010; 59: 3181-91.